---
title: "Top 10 US Stock Gainers (9.4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298078807.md"
description: "Tyra Biosciences(TYRA) rose 15.25%, with a trading turnover 52.9 Million USD, and a year-to-date rose 9%. Belite Bio(BLTE) rose 13.16%, with a trading turnover 137.5 Million USD, and a year-to-date rose 21%. Aehr Test(AEHR) rose 13.1%, with a trading turnover 377.1 Million USD, and a year-to-date rose 327.2%."
datetime: "2026-09-04T22:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298078807.md)
  - [en](https://longbridge.com/en/news/298078807.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298078807.md)
generator: "portal-rs"
---

# Top 10 US Stock Gainers (9.4)

NASDAQ Composite Index has fell 0.29%, with a year-to-date rose 14%; S&P 500 has fell 0.38%, with a year-to-date rose 12.8%; Dow Jones Industrial Average has fell 0.51%, with a year-to-date rose 11.1%.

Tyra Biosciences(TYRA) rose 15.25%, with a trading turnover 52.9 Million USD, and a year-to-date rose 9%.

Belite Bio(BLTE) rose 13.16%, with a trading turnover 137.5 Million USD, and a year-to-date rose 21%.

Aehr Test(AEHR) rose 13.1%, with a trading turnover 377.1 Million USD, and a year-to-date rose 327.2%.

### Related Stocks

- [TYRA.US](https://longbridge.com/en/quote/TYRA.US.md)
- [BLTE.US](https://longbridge.com/en/quote/BLTE.US.md)
- [AEHR.US](https://longbridge.com/en/quote/AEHR.US.md)
- [SNDK.US](https://longbridge.com/en/quote/SNDK.US.md)
- [GOLD.US](https://longbridge.com/en/quote/GOLD.US.md)
- [EOSE.US](https://longbridge.com/en/quote/EOSE.US.md)
- [CBRS.US](https://longbridge.com/en/quote/CBRS.US.md)
- [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md)
- [AXTI.US](https://longbridge.com/en/quote/AXTI.US.md)
- [SMTC.US](https://longbridge.com/en/quote/SMTC.US.md)

## Related News & Research

- [Tyra Biosciences: Buy Rating Reiterated as SURF302 Data Upside Beckons; 12‑Month Price Target Maintained at $45](https://longbridge.com/en/news/298055291.md)
- [Tyra Biosciences to present initial Phase 2 SURF302 data for oral dabogratinib in intermediate-risk bladder cancer on Sept. 9](https://longbridge.com/en/news/298034950.md)
- [Aehr Test Systems CEO, CFO to meet investors at Lake Street Best Ideas Growth Conference](https://longbridge.com/en/news/297952727.md)
- [Gold.com (NYSE:GOLD) Announces Earnings Results](https://longbridge.com/en/news/297828749.md)
- [13,894 Shares in Semtech Corporation $SMTC Purchased by Two Sigma Securities LLC](https://longbridge.com/en/news/297500493.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**